RHBC
AKRX

R.H. Bluestein & Co’s Akorn Inc AKRX Stock Holding History

R.H. Bluestein & Co’s Portfolio AKRX Stock Details AKRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-23,300
Closed -$1.02M – 330
2015
Q2 		$1.02M Buy
+23,300
New +$1.08M 0.06% 94

Other funds holding AKRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

R.H. Bluestein & Co's AKRX Position: Q3 2015 in Review

R.H. Bluestein & Co sold out of Akorn Inc (AKRX) in Q3 2015, closing a stake of 23,300 shares — an estimated $1.02M sold.

R.H. Bluestein & Co first reported a position in AKRX in Q2 2015 and held it in 1 quarter. The position peaked at $1.02M in Q2 2015. 304 funds tracked by Wall St. Rank hold AKRX as of Q3 2015.

  • R.H. Bluestein & Co reported no remaining Akorn Inc position as of Q3 2015 after selling out during the quarter.
  • R.H. Bluestein & Co sold 23,300 Akorn Inc shares in Q3 2015, an estimated $1.02M.
  • R.H. Bluestein & Co first reported a position in Akorn Inc in Q2 2015 and held it in 1 quarter.
  • R.H. Bluestein & Co's Akorn Inc position peaked at $1.02M in Q2 2015.
  • 304 funds tracked by Wall St. Rank held Akorn Inc as of Q3 2015.

Based on R.H. Bluestein & Co's 13F filing for Q3 2015, filed 13 Nov 2015.